+1,100.9%
MRNA vs THC
+1,095.8%
+5.1%
-95.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for all.
| Period | Portfolio | THC | Excess | Alpha |
|---|---|---|---|---|
| 1D | -3.4% | -0.3% | -3.2% | -3.4% |
| 7D | -12.1% | +1.0% | -13.1% | -12.2% |
| 30D | -1.3% | +5.3% | -6.6% | -1.7% |
| 3M | +250.9% | +7.1% | +243.8% | +248.6% |
| 6M | +343.0% | +46.0% | +297.0% | +326.0% |
| YTD | +657.4% | +43.9% | +613.5% | +626.9% |
| 1Y | +794.9% | +45.4% | +749.5% | +757.5% |
| 3Y | +218.1% | +421.3% | -203.1% | +171.0% |
| 5Y | -3.4% | +261.5% | -264.9% | -17.0% |
| All | +1,100.9% | +1,095.8% | +5.1% | +869.7% |
Cumulative growth
Daily Returns
Daily percentage return beside THC.
Daily Out/Under-Performance
Portfolio return minus THC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × THC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over all: compounded portfolio wealth divided by compounded THC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
all analysis · Full analysis span regression · 6 months rolling